Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amer A Beg

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung CancerJhanelle E Gray, Andreas Saltos, Tawee Tanvetyanon, et al.
Nature|May 25, 2022
ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosisTing Zhang, Chaoran Yin, Aleksandr Fedorov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2022
Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non-Small Cell Lung CancerAlberto A Chiappori, Ben Creelan, Tawee Tanvetyanon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 9, 2024
Rapid Autopsy to Define Dendritic Cell Spatial Distribution and T Cell Association in Lung AdenocarcinomaHilal Ozakinci, Xiaofei Song, Gina S Nazario, et al.
The Journal of Clinical Investigation|March 24, 2007
Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophySwarnali Acharyya, S Armando Villalta, Nadine Bakkar, et al.
Nature Communications|August 10, 2019
Proteogenomic landscape of squamous cell lung cancerPaul A Stewart, Eric A Welsh, Robbert J C Slebos, et al.
Cancer Discovery|August 27, 2024
RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal HematopoiesisNana Adjoa Ben-Crentsil, Wazim Mohammed Ismail, Maria E Balasis, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung CancerJhanelle E Gray, Andreas Saltos, Tawee Tanvetyanon, et al.
Nature|May 25, 2022
ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosisTing Zhang, Chaoran Yin, Aleksandr Fedorov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2022
Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non-Small Cell Lung CancerAlberto A Chiappori, Ben Creelan, Tawee Tanvetyanon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 9, 2024
Rapid Autopsy to Define Dendritic Cell Spatial Distribution and T Cell Association in Lung AdenocarcinomaHilal Ozakinci, Xiaofei Song, Gina S Nazario, et al.
The Journal of Clinical Investigation|March 24, 2007
Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophySwarnali Acharyya, S Armando Villalta, Nadine Bakkar, et al.
Nature Communications|August 10, 2019
Proteogenomic landscape of squamous cell lung cancerPaul A Stewart, Eric A Welsh, Robbert J C Slebos, et al.
Cancer Discovery|August 27, 2024
RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal HematopoiesisNana Adjoa Ben-Crentsil, Wazim Mohammed Ismail, Maria E Balasis, et al.
Pageof 6